Enhanced antitumour efficacy of ferulic acid nanoparticles in combination with doxorubicin – a promising strategy for breast cancer treatment
The combination of FA with DOX has the ability not only to promote the antitumour activity of DOX but also to ameliorate the side effects of DOX with more significant results when the FA was formulated by the nanotechnology.
Authors
- Tarek M. Okda (ORCID: https://orcid.org/0000-0001-7030-6169)
- Ahmad Salahuddin (ORCID: https://orcid.org/0000-0002-7382-4284)
- Hisham Abdel‐Azim (ORCID: https://orcid.org/0000-0003-0880-8701)
- Ahmed E. Noreldin (ORCID: https://orcid.org/0000-0002-8344-0807)
- Gamal A. Omran (ORCID: https://orcid.org/0000-0002-1609-8802)
- Atef Kamel Salama
Institutions
- Damanhour University (EG)
Publication Details
- Journal
- Współczesna Onkologia
- Published
- 2025-01-01
- DOI
- https://doi.org/10.5114/wo.2025.151917
- Primary Topic
- Curcumin's Biomedical Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00